*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Georgia Tech's Bioengineering and Bioscience Unified Graduate Students (BBUGS) presents: "Healthcare Reform and Biomedical Innovation."
New health technologies have contributed to large increases in health care costs. Are we getting the bang for our buck? Should cost-control be a priority? Or is this a futile quest for perfect health with marginal gains?
This talk will review the research on the value of new medical technologies and discuss the impact of health reform on the pace of technological innovation in medicine.
David Howard is an Associate Professor in the Department of Health Policy and Management at Emory University. A health economist by training, Dr. Howard’s research employs economics and statistics to better understand physician decision-making and its implications for public policy. Dr. Howard’s current areas of research include: the impact of patients’ life expectancy on the use of cancer screening, the impact of quality and outcomes on patients’ choice of provider, and the value of medical care for cancer. Dr. Howard is also studying the impact of waiting time on transplant candidate’s choice of living versus deceased donor transplantation. Dr. Howard has acted as an advisor or consultant to MEDPAC, the American Cancer Society, the Division of Transplantation in the Department of Health and Human Services, and the Institute of Medicine. Dr. Howard received his doctorate in health policy from Harvard University in 2000.
